FoRx raises $50 million series A with EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund and M Ventures
08 December 2025
08 December 2025
Total investments received (USD): 60.87M
Round value (USD): 50M
Company: FoRx
Related deals
Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital
Investments
01 July 2025
vVARDIS to secure $50 million in an equity financing round led by OrbiMed
Investments
30 June 2025
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Portugal
Spain